CIAM
UTHR icon

Caitong International Asset Management’s United Therapeutics UTHR Stock Holding History

Caitong International Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5K Buy
+25
New +$14.1K ﹤0.01% 1083
2025
Q4 		– Sell
-643
Closed -$270K – 2392
2025
Q3 		$270K Buy
643
+640
+21,333% +$215K 0.19% 54
2025
Q2 		$862 Buy
+3
New +$897 ﹤0.01% 1601

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caitong International Asset Management's UTHR Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 25 shares worth $13.5K. The stake represents ﹤0.01% of the portfolio and ranks #1083 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in UTHR as recently as Q3 2025.

Caitong International Asset Management first reported a position in UTHR in Q2 2025 and has held it in 3 quarters since. The position peaked at $270K in Q3 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Caitong International Asset Management held 25 shares of United Therapeutics worth $13.5K as of Q2 2026.
  • United Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1083 holding.
  • Caitong International Asset Management first reported a position in United Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's United Therapeutics position peaked at $270K in Q3 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.